Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 135th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
BCRX	BIOCRYST PHARMACEUTICALS INC	$6.38	2.24%	-3.04%	-15.83%	-9.25%	-25.81%	-26.92%	-40.04%	-37.76%	258.43%	$11.31	$6.00	43.59%	6.33%	1.17	6,346,000	40.49%
JAZZ	JAZZ PHARMACEUTICALS PLC	$165.50	1.44%	0.61%	-0.89%	23.46%	56.24%	37.84%	8.08%	-0.31%	44.97%	$182.99	$95.49	9.56%	73.32%	0.70	703,000	11.94%
PHAR	PHARMING GROUP NV	$16.09	0.31%	-21.40%	-4.57%	9.46%	30.92%	81.40%	21.07%	13.47%	N/A	$21.34	$7.50	24.60%	114.48%	0.56	38,000	-43.28%
MDXG	MIMEDX GROUP INC	$5.15	2.39%	0.78%	-19.53%	-29.74%	-28.87%	-39.41%	14.70%	-51.55%	-33.46%	$8.54	$4.89	39.70%	5.32%	1.29	847,000	-2.87%
AUPH	AURINIA PHARMACEUTICALS INC	$14.44	1.26%	-0.62%	-6.48%	3.51%	24.38%	78.49%	58.68%	-13.43%	457.53%	$16.54	$6.55	12.70%	120.46%	1.11	878,000	0.80%
MIRM	MIRUM PHARMACEUTICALS INC	$100.47	2.28%	-2.66%	31.40%	48.36%	88.18%	96.12%	324.64%	370.59%	N/A	$105.74	$36.88	4.98%	172.42%	0.72	589,000	-11.69%
INVA	INNOVIVA INC	$21.80	1.07%	9.00%	12.89%	5.93%	19.45%	19.39%	71.52%	73.43%	98.18%	$22.76	$16.52	4.22%	31.96%	0.40	651,000	-9.21%
EXEL	EXELIXIS INC	$43.90	3.61%	6.14%	0.50%	7.60%	16.41%	30.38%	154.20%	84.38%	932.94%	$49.62	$32.38	11.53%	35.58%	0.63	3,365,000	41.27%
VCYT	VERACYTE INC	$36.19	3.82%	-4.96%	-20.71%	-13.19%	50.98%	-16.80%	41.59%	-53.16%	556.81%	$50.71	$22.61	28.63%	60.06%	1.96	1,203,000	22.13%
TVTX	TRAVERE THERAPEUTICS INC	$29.71	0.81%	-4.44%	-17.01%	-10.78%	72.33%	35.91%	34.43%	-4.32%	109.82%	$42.13	$12.91	29.48%	130.13%	1.12	1,333,000	-24.77%
HALO	HALOZYME THERAPEUTICS INC	$81.23	3.58%	13.28%	11.08%	18.77%	30.34%	40.20%	56.69%	61.17%	1,009.70%	$81.36	$47.50	0.15%	71.01%	0.84	2,245,000	-9.51%
ALNY	ALNYLAM PHARMACEUTICALS INC	$328.16	-0.93%	-2.93%	-19.25%	-25.50%	-23.35%	17.94%	46.41%	98.70%	441.43%	$495.55	$205.87	33.78%	59.40%	0.90	1,458,000	-43.99%
INCY	INCYTE CORP	$108.39	5.48%	8.31%	1.62%	3.03%	39.59%	44.62%	28.49%	15.78%	52.86%	$112.29	$53.56	3.47%	102.37%	0.56	2,194,000	7.18%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$27.32	4.79%	7.69%	-6.50%	8.84%	77.86%	119.97%	65.38%	-26.12%	N/A	$31.77	$11.13	14.01%	145.46%	1.20	1,363,000	-11.44%
ONC	BEONE MEDICINES LTD	$353.92	1.99%	3.98%	10.48%	6.49%	18.56%	54.64%	44.35%	-4.10%	1,022.84%	$385.22	$196.45	8.13%	80.16%	0.98	268,000	-35.89%
RPRX	ROYALTY PHARMA PLC	$44.65	1.25%	7.13%	9.84%	9.49%	20.29%	42.20%	16.67%	-7.67%	N/A	$44.93	$29.66	0.61%	50.54%	0.48	3,535,000	-40.18%
TBPH	THERAVANCE BIOPHARMA INC	$20.48	4.60%	8.13%	11.91%	37.73%	83.18%	115.35%	92.84%	2.40%	20.40%	$21.03	$7.90	2.62%	159.24%	0.62	778,000	121.02%
VRTX	VERTEX PHARMACEUTICALS INC	$477.92	4.17%	1.71%	2.04%	14.82%	23.93%	-0.67%	56.76%	122.94%	482.83%	$519.68	$362.50	8.04%	31.84%	0.57	1,622,000	-3.05%
APLS	APELLIS PHARMACEUTICALS INC	$23.49	4.12%	4.03%	-1.88%	19.18%	-1.01%	-22.22%	-57.45%	-52.18%	N/A	$30.48	$16.10	22.93%	45.90%	0.99	1,825,000	-37.99%
NAGE	NIAGEN BIOSCIENCE INC	$5.20	1.36%	-13.19%	-23.08%	-21.21%	-44.68%	-8.61%	175.13%	-9.57%	31.31%	$14.69	$5.05	64.60%	2.97%	1.37	1,111,000	-9.89%
IDYA	IDEAYA BIOSCIENCES INC	$32.17	1.26%	-0.06%	-11.40%	7.77%	36.14%	34.27%	86.28%	53.56%	N/A	$39.28	$13.45	18.10%	139.18%	1.10	985,000	53.19%
FENC	FENNEC PHARMACEUTICALS INC	$7.84	2.35%	3.29%	6.23%	-2.00%	-3.92%	17.72%	-19.26%	-8.73%	361.18%	$9.92	$4.68	20.97%	67.52%	0.64	91,000	-19.47%
RIGL	RIGEL PHARMACEUTICALS INC	$34.15	2.80%	-2.04%	-21.10%	-5.45%	14.56%	40.02%	99.71%	-30.73%	42.29%	$52.24	$15.50	34.63%	120.32%	1.34	354,000	-16.11%
GYRE	GYRE THERAPEUTICS INC	$7.88	4.93%	-2.60%	13.06%	7.36%	12.25%	-38.20%	84.33%	-91.08%	-98.40%	$13.75	$6.11	42.69%	28.97%	1.29	47,500	2.15%
VCEL	VERICEL CORP	$36.19	2.29%	0.58%	-8.01%	-6.61%	-0.28%	-39.38%	18.27%	-27.12%	1,674.02%	$59.17	$29.24	38.84%	23.77%	1.49	499,000	13.41%
TGTX	TG THERAPEUTICS INC	$28.86	3.96%	-1.94%	-1.87%	-13.23%	4.19%	-13.85%	56.17%	-44.96%	257.18%	$46.48	$25.28	37.91%	14.16%	1.90	1,622,000	-36.91%
SEPN	SEPTERNA INC	$25.41	3.97%	8.87%	-0.16%	35.16%	116.26%	78.82%	N/A	N/A	N/A	$30.50	$4.17	16.69%	509.35%	1.37	280,000	-27.46%
ANAB	ANAPTYSBIO INC	$49.73	3.82%	4.89%	13.25%	30.18%	120.63%	209.27%	92.60%	67.38%	N/A	$52.47	$12.21	5.22%	307.29%	0.88	501,000	-15.80%
AKBA	AKEBIA THERAPEUTICS INC	$1.39	0.72%	-1.42%	-5.44%	-30.85%	-63.28%	-35.65%	29.91%	-72.53%	-80.56%	$4.08	$1.30	65.92%	6.92%	1.47	3,421,000	4.55%
MNKD	MANNKIND CORP	$5.78	4.90%	0.00%	2.85%	1.40%	66.81%	2.30%	12.02%	14.23%	32.36%	$6.51	$3.38	11.21%	70.96%	1.11	3,012,000	-4.95%
TARS	TARSUS PHARMACEUTICALS INC	$64.62	4.24%	0.12%	-19.10%	-5.10%	55.19%	21.19%	310.03%	59.16%	N/A	$85.25	$38.51	24.20%	67.80%	0.91	800,000	32.23%
LGND	LIGAND PHARMACEUTICALS INC	$190.44	-0.65%	-0.86%	-2.85%	-8.54%	33.74%	61.61%	165.68%	-8.54%	114.48%	$212.49	$93.58	10.38%	103.51%	1.16	273,000	40.72%
FBIO	FORTRESS BIOTECH INC	$3.27	11.60%	5.48%	-22.33%	29.76%	73.94%	78.69%	-73.70%	-94.58%	-91.84%	$4.53	$1.33	27.81%	146.79%	1.20	620,000	38.08%
ZVRA	ZEVRA THERAPEUTICS INC	$8.60	2.87%	-4.44%	3.49%	-5.39%	-25.09%	9.14%	54.68%	-8.90%	-95.32%	$13.16	$6.19	34.65%	38.93%	0.89	604,000	-20.21%
PTCT	PTC THERAPEUTICS INC	$74.68	3.21%	-1.13%	-2.63%	2.88%	45.40%	49.99%	61.54%	16.80%	219.55%	$87.50	$35.95	14.65%	107.73%	0.98	1,040,000	-21.75%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$37.27	2.36%	2.05%	1.41%	20.46%	7.50%	-3.89%	-24.78%	-7.68%	N/A	$40.87	$25.52	8.81%	46.04%	0.82	568,000	49.87%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$15.77	-4.25%	-14.76%	-2.11%	1.35%	34.90%	96.88%	66.35%	-74.30%	N/A	$20.76	$6.26	24.04%	152.12%	2.06	4,140,000	65.80%
TNGX	TANGO THERAPEUTICS INC	$12.51	4.69%	7.75%	29.37%	56.18%	92.46%	283.74%	92.46%	10.22%	N/A	$13.46	$1.03	7.06%	1,114.56%	1.24	2,509,000	7.31%
PBYI	PUMA BIOTECHNOLOGY INC	$6.94	2.21%	7.10%	18.43%	41.63%	113.54%	140.14%	53.54%	-46.33%	-81.15%	$7.29	$2.58	4.74%	169.51%	0.98	409,000	-5.76%
FHTX	FOGHORN THERAPEUTICS INC	$5.68	8.60%	-0.53%	15.21%	42.00%	15.92%	37.86%	-29.62%	-68.16%	N/A	$6.95	$2.95	18.27%	92.87%	1.54	222,000	-5.13%
XERS	XERIS BIOPHARMA HOLDINGS INC	$7.01	1.45%	-4.76%	0.72%	-9.08%	27.69%	93.65%	494.07%	-4.23%	N/A	$10.08	$3.45	30.46%	103.48%	1.23	948,000	-28.88%
CPRX	CATALYST PHARMACEUTICALS INC	$24.44	2.22%	0.58%	8.24%	16.44%	12.16%	5.98%	54.00%	438.33%	1,363.47%	$26.58	$19.05	8.05%	28.29%	1.03	1,031,000	-17.91%
NBP	NOVABRIDGE BIOSCIENCES	$3.70	11.11%	11.78%	-4.64%	-11.69%	-1.07%	283.82%	-28.16%	-93.62%	N/A	$6.79	$0.60	45.51%	521.85%	1.30	546,000	19.74%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$43.09	1.20%	-1.89%	0.96%	11.55%	31.69%	112.37%	202.60%	87.10%	N/A	$45.50	$18.12	5.30%	137.80%	0.84	313,000	-6.29%
SLNO	SOLENO THERAPEUTICS INC	$41.53	4.93%	7.70%	-9.99%	-4.62%	-48.85%	-18.54%	1,690.09%	-16.10%	-54.24%	$90.32	$37.95	54.02%	9.43%	0.43	1,459,000	18.43%
SPRO	SPERO THERAPEUTICS INC	$2.42	5.22%	10.50%	-3.59%	1.26%	7.08%	180.42%	28.04%	-88.73%	N/A	$3.22	$0.51	24.84%	379.21%	0.77	1,028,000	37.25%
REGN	REGENERON PHARMACEUTICALS INC	$785.51	2.46%	5.94%	1.16%	21.43%	41.50%	8.79%	0.60%	58.72%	101.14%	$821.11	$476.49	4.34%	64.85%	0.60	671,000	-31.18%
GMAB	GENMAB A	$30.90	-0.23%	-5.30%	-6.65%	7.14%	43.65%	59.69%	-20.63%	-23.82%	209.56%	$35.43	$17.24	12.79%	79.29%	0.73	1,760,000	15.79%
ACAD	ACADIA PHARMACEUTICALS INC	$23.56	0.43%	-6.25%	-12.55%	8.82%	-1.01%	23.16%	18.69%	-54.06%	32.66%	$28.35	$13.40	16.90%	75.82%	0.93	2,356,000	98.82%
VRCA	VERRICA PHARMACEUTICALS INC	$6.91	4.54%	-1.71%	-14.16%	93.02%	13.00%	1.07%	-87.01%	-95.41%	N/A	$9.82	$3.28	29.64%	110.67%	0.98	124,000	-49.39%
PRLD	PRELUDE THERAPEUTICS INC	$2.17	7.43%	17.30%	-15.23%	60.74%	155.29%	95.50%	-69.61%	-97.47%	N/A	$4.22	$0.61	48.58%	255.74%	1.50	222,000	-37.64%
IMCR	IMMUNOCORE HOLDINGS PLC	$31.98	3.43%	-1.75%	-2.65%	1.22%	-0.37%	6.71%	-49.48%	-43.24%	N/A	$40.72	$23.15	21.45%	38.14%	0.74	500,000	-56.26%
ARGX	ARGENX SE	$811.45	-1.08%	-3.46%	0.96%	-4.65%	20.55%	23.33%	117.38%	121.04%	N/A	$934.62	$510.06	13.18%	59.09%	0.64	371,000	-23.35%
XOMA	XOMA ROYALTY CORP	$24.86	-0.24%	-3.12%	-6.01%	-27.03%	-5.90%	-4.79%	21.86%	-43.49%	62.08%	$39.92	$18.35	37.73%	35.46%	0.84	400,000	103.05%
BMRN	BIOMARIN PHARMACEUTICAL INC	$58.13	1.71%	2.81%	-3.23%	12.13%	-4.19%	-9.65%	-48.18%	-32.63%	-10.21%	$73.51	$50.76	20.92%	14.52%	0.73	1,644,000	30.79%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$2.26	4.40%	-9.44%	-13.27%	-43.34%	-16.17%	-10.52%	-25.08%	-92.23%	N/A	$4.94	$1.20	54.35%	88.70%	1.62	711,000	0.28%
BNTX	BIONTECH SE	$106.62	1.02%	-6.27%	8.70%	3.16%	-4.20%	-11.11%	-24.36%	-10.78%	N/A	$124.49	$81.20	14.35%	31.31%	0.98	740,000	6.94%
KRYS	KRYSTAL BIOTECH INC	$272.74	1.91%	-2.33%	9.36%	36.39%	100.54%	69.34%	241.14%	289.63%	N/A	$295.98	$122.80	7.85%	122.10%	1.37	328,000	13.89%
TECH	BIO-TECHNE CORP	$66.78	1.40%	4.20%	2.30%	14.78%	33.91%	-10.97%	-11.63%	-31.61%	214.33%	$72.16	$46.01	7.46%	45.14%	1.18	1,547,000	-42.51%
ZYME	ZYMEWORKS INC	$22.72	3.18%	0.84%	-6.04%	26.93%	83.08%	52.38%	131.36%	-45.31%	N/A	$28.49	$9.03	20.25%	151.61%	0.96	576,000	-6.95%
AXSM	AXSOME THERAPEUTICS INC	$182.55	0.95%	-0.92%	6.21%	30.94%	76.79%	66.71%	178.92%	142.53%	3,299.44%	$191.50	$86.99	4.67%	109.85%	0.91	652,000	-26.82%
LXRX	LEXICON PHARMACEUTICALS INC	$1.23	4.24%	6.03%	7.89%	-13.99%	6.96%	66.22%	-48.54%	-85.84%	-84.89%	$1.83	$0.28	32.79%	333.10%	1.50	2,086,000	-69.88%
DOMH	DOMINARI HOLDINGS INC	$3.73	9.71%	-4.60%	-12.85%	-19.61%	-33.39%	32.74%	-8.35%	-87.02%	-97.77%	$13.58	$3.03	72.53%	23.10%	1.32	100,000	-30.56%
KROS	KEROS THERAPEUTICS INC	$17.57	1.91%	-1.90%	-1.24%	8.66%	21.93%	52.58%	-68.74%	-75.25%	N/A	$22.55	$9.12	22.08%	92.65%	1.11	305,000	13.81%
LQDA	LIQUIDIA CORP	$43.04	3.56%	1.53%	40.10%	68.13%	111.92%	169.67%	523.77%	1,140.35%	N/A	$46.67	$11.26	7.78%	282.24%	1.07	1,504,000	4.66%
VRDN	VIRIDIAN THERAPEUTICS INC	$29.25	0.27%	-11.36%	-4.79%	6.36%	70.06%	58.02%	-18.30%	47.28%	-75.13%	$34.29	$9.90	14.70%	195.45%	0.94	1,940,000	-7.04%
FTRE	FORTREA HOLDINGS INC	$14.65	6.16%	-12.85%	-16.48%	32.94%	122.64%	-4.87%	N/A	N/A	N/A	$18.67	$3.97	21.53%	269.02%	1.74	1,652,000	-47.97%
UTHR	UNITED THERAPEUTICS CORP	$485.36	1.34%	3.38%	-3.45%	6.91%	60.50%	37.20%	90.16%	186.69%	319.32%	$519.99	$266.98	6.66%	81.80%	0.44	297,000	-31.41%
NBTX	NANOBIOTIX SA	$20.85	-0.86%	-0.71%	2.36%	6.00%	202.17%	492.33%	440.16%	15.64%	N/A	$30.35	$2.95	31.30%	606.78%	1.00	6,300	31.25%
EVAX	EVAXION A	$3.36	15.46%	5.66%	-33.47%	-46.33%	18.73%	22.18%	-96.27%	-99.32%	N/A	$12.15	$1.20	72.35%	180.00%	0.63	62,000	-36.73%
CORT	CORCEPT THERAPEUTICS INC	$40.83	6.44%	2.41%	14.11%	-44.11%	-42.10%	-39.99%	70.41%	33.61%	1,086.92%	$117.33	$32.99	65.20%	23.76%	0.96	1,385,000	30.17%
STTK	SHATTUCK LABS INC	$3.77	5.60%	-2.58%	-5.28%	92.35%	360.32%	204.03%	-14.90%	-92.82%	N/A	$4.89	$0.69	22.90%	444.80%	1.41	419,000	-15.18%
CRMD	CORMEDIX INC	$7.69	4.63%	-0.90%	-31.71%	-28.66%	-35.65%	-26.76%	72.42%	-48.42%	1.85%	$17.43	$5.60	55.88%	37.32%	1.06	1,574,000	-13.61%
CTXR	CITIUS PHARMACEUTICALS INC	$0.76	6.04%	2.03%	-22.96%	-39.11%	-41.02%	-71.51%	-97.73%	-97.73%	N/A	$2.97	$0.63	74.58%	19.84%	1.05	477,000	-72.19%
SABS	SAB BIOTHERAPEUTICS INC	$4.17	4.77%	-5.01%	15.19%	34.52%	90.41%	96.70%	-42.88%	-96.05%	N/A	$6.60	$1.00	36.82%	317.00%	0.69	384,000	31.96%
ASMB	ASSEMBLY BIOSCIENCES INC	$26.22	3.27%	1.71%	-14.26%	-16.58%	34.95%	91.67%	31.63%	-66.12%	-53.71%	$39.71	$7.75	33.96%	238.32%	0.90	56,000	-42.86%
CGON	CG ONCOLOGY INC	$50.36	2.36%	-3.25%	24.75%	26.88%	99.13%	67.70%	N/A	N/A	N/A	$57.88	$14.80	12.99%	240.27%	1.56	842,000	-22.11%
ORMP	ORAMED PHARMACEUTICALS INC	$3.41	5.25%	1.19%	11.07%	55.00%	63.55%	54.30%	63.94%	-67.31%	-43.45%	$3.71	$1.82	8.09%	87.36%	1.23	167,000	-20.85%
MESO	MESOBLAST LTD	$15.95	-0.81%	-7.54%	-14.11%	6.83%	1.85%	-14.66%	101.39%	-22.50%	54.85%	$21.50	$9.61	25.81%	65.97%	1.31	284,000	-2.74%
ADMA	ADMA BIOLOGICS INC	$16.43	3.07%	-5.03%	-10.41%	17.11%	-11.38%	-2.90%	342.86%	499.64%	227.94%	$25.67	$13.50	36.00%	21.70%	1.21	1,589,000	-22.79%
PTN	PALATIN TECHNOLOGIES INC	$15.72	-2.06%	6.87%	-10.68%	106.30%	28.33%	-68.24%	-92.08%	-98.74%	-97.67%	$58.00	$1.75	72.90%	798.29%	1.21	9,500	-56.82%
PYPD	POLYPID LTD	$4.52	3.91%	-1.31%	-1.09%	18.95%	38.65%	55.86%	-81.55%	-98.64%	N/A	$5.12	$2.30	11.72%	96.52%	0.77	37,300	-43.74%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$64.52	-0.19%	-6.94%	-8.88%	62.93%	295.59%	215.04%	92.54%	-27.02%	1,891.36%	$76.76	$9.57	15.95%	574.19%	1.67	24,091,000	642.17%
ENTA	ENANTA PHARMACEUTICALS INC	$13.51	4.16%	4.73%	-0.52%	25.09%	89.75%	172.38%	-74.48%	-75.41%	-37.22%	$17.15	$4.09	21.22%	230.32%	0.99	164,000	-7.34%
IBRX	IMMUNITYBIO INC	$6.05	7.27%	-3.20%	182.71%	185.38%	154.20%	82.78%	39.72%	-77.43%	-11.03%	$8.28	$1.83	26.93%	230.60%	2.16	18,256,000	-1.06%
ARDX	ARDELYX INC	$7.32	4.57%	-4.81%	31.65%	29.56%	40.77%	29.10%	127.33%	-3.56%	-19.56%	$8.40	$3.21	12.86%	128.04%	1.14	3,184,000	-41.30%
INBX	INHIBRX BIOSCIENCES INC	$83.91	2.92%	10.02%	10.26%	3.61%	299.95%	547.95%	N/A	N/A	N/A	$94.57	$10.81	11.27%	676.58%	1.11	143,000	-3.38%
AGEN	AGENUS INC	$2.94	6.14%	3.52%	-15.27%	-23.44%	-38.24%	-21.39%	-94.26%	-97.20%	-94.84%	$7.34	$1.38	59.95%	113.04%	1.75	490,000	-0.20%
CLLS	CELLECTIS SA	$3.57	2.00%	-5.80%	-18.86%	14.06%	31.73%	124.53%	42.80%	-87.27%	-81.65%	$5.48	$1.10	34.85%	224.55%	1.44	18,800	-78.39%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$9.77	5.74%	5.39%	9.41%	-0.81%	97.37%	N/A	N/A	N/A	N/A	$25.00	$3.20	60.92%	205.31%	-0.40	76,000	-12.64%
ALDX	ALDEYRA THERAPEUTICS INC	$5.53	8.64%	3.17%	36.21%	14.97%	5.94%	-7.83%	-10.66%	-54.82%	40.36%	$7.20	$1.14	23.19%	385.09%	1.24	974,000	60.46%
LYEL	LYELL IMMUNOPHARMA INC	$22.71	0.31%	-5.38%	-11.74%	27.01%	104.96%	92.13%	-65.49%	N/A	N/A	$45.00	$7.65	49.53%	196.86%	1.58	125,000	20.19%
PLX	PROTALIX BIOTHERAPEUTICS INC	$2.89	-0.69%	23.50%	63.28%	30.18%	95.27%	7.43%	76.22%	-50.34%	-63.18%	$3.10	$1.32	6.77%	118.94%	0.71	2,558,000	7.07%
PHAT	PHATHOM PHARMACEUTICALS INC	$12.58	1.37%	-7.97%	-23.15%	-3.53%	44.93%	113.22%	4.92%	-71.25%	N/A	$18.31	$2.21	31.29%	469.23%	1.43	951,000	-22.49%
SLN	SILENCE THERAPEUTICS PLC	$4.75	5.09%	-1.45%	-17.10%	-26.36%	-10.71%	-17.39%	-63.41%	-81.34%	N/A	$7.78	$1.97	38.91%	141.12%	0.64	200,000	-34.64%
ERAS	ERASCA INC	$12.29	3.45%	16.94%	238.57%	448.66%	759.44%	635.93%	189.86%	N/A	N/A	$12.47	$1.01	1.44%	1,116.83%	1.36	4,305,000	-28.38%
ASND	ASCENDIS PHARMA A	$222.15	2.19%	-1.75%	6.14%	11.48%	21.66%	77.69%	94.61%	44.32%	1,118.60%	$242.00	$118.03	8.20%	88.21%	0.72	806,000	-39.44%
DAWN	DAY ONE BIOPHARMACEUTICALS INC	$11.41	8.87%	2.24%	32.06%	26.92%	96.72%	-8.79%	-46.26%	N/A	N/A	$13.20	$5.64	13.56%	102.48%	0.78	3,130,000	16.10%
UNCY	UNICYCIVE THERAPEUTICS INC	$6.69	8.08%	12.06%	18.41%	49.33%	61.20%	9.85%	26.23%	N/A	N/A	$68.99	$3.71	90.30%	80.32%	0.71	594,000	1.19%
UPB	UPSTREAM BIO INC	$26.20	0.77%	-15.70%	1.28%	10.74%	56.70%	207.15%	N/A	N/A	N/A	$33.68	$5.14	22.21%	409.73%	1.16	517,000	-16.48%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #1 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 15, which is -9 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 5 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -26.92% over the past year, overperforming other biotech stocks by 4 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $21.86, an upside of 242.59% from Biocryst Pharmaceuticals's current stock price of $6.38.

Biocryst Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Biocryst Pharmaceuticals, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -8 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 37.84% over the past year, overperforming other biotech stocks by 69 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $213.27, an upside of 28.87% from Jazz Pharmaceuticals's current stock price of $165.50.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top biotech stock out of 610 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: B, Safety: C, Financials: C, and AI: B.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 33, which is 9 points higher than the biotech industry average of 24.

PHAR passed 10 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 81.4% over the past year, overperforming other biotech stocks by 112 percentage points.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 26.41%, which is 21 percentage points higher than the biotech industry average of 5.56%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.33%, which is 2 percentage points higher than the biotech industry average of 5.56%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.97%, which is -4 percentage points lower than the biotech industry average of 5.56%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.73% in the last day, and down -0.36% over the last week. Roivant Sciences was the among the top gainers in the biotechnology industry, gaining 22.14% yesterday.

Roivant Sciences shares are trading higher after the company reported better-than-expected Q3 sales results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the biotech industry average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -3.89% in the past year. It has overperformed other stocks in the biotech industry by 27 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Innoviva's stock has gained 19.39% in the past year. It has overperformed other stocks in the biotech industry by 50 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 41 points higher than the biotech industry average of 16. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 44.62% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

64.15% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.9% over the next year.

3.35% of biotech stocks have a Zen Rating of A (Strong Buy), 6.5% of biotech stocks are rated B (Buy), 41.93% are rated C (Hold), 37.53% are rated D (Sell), and 10.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 234.95x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Biocryst Pharmaceuticals (NASDAQ:BCRX)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.